Compare Stocks → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CANCNYSEARCA:GREINYSEARCA:SIMSNYSEARCA:XPND Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCANCTema Oncology ETF$25.94+1.8%$27.30$21.26▼$29.16$17.64M1.07564 shs200 shsGREIGoldman Sachs Future Real Estate and Infrastructure Equity ETF$31.88-0.1%$32.64$28.76▼$35.12$19.13M0.81,640 shs100 shsSIMSSPDR S&P Kensho Intelligent Structures ETF$32.93+1.0%$33.61$28.11▼$38.18$16.79M1.344,165 shs300 shsXPNDFirst Trust Expanded Technology ETF$25.62+1.9%$26.10$17.60▼$26.88$17.93M1.386,204 shs4,700 shs(Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCANCTema Oncology ETF0.00%+2.65%-7.75%-3.28%+2,593,999,900.00%GREIGoldman Sachs Future Real Estate and Infrastructure Equity ETF0.00%+1.08%-5.06%-3.51%-6.63%SIMSSPDR S&P Kensho Intelligent Structures ETF0.00%+3.62%-4.99%+1.37%+1.44%XPNDFirst Trust Expanded Technology ETF0.00%+4.20%-3.47%+1.66%+41.51%He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right hereMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCANCTema Oncology ETFN/AN/AN/AN/AN/AN/AN/AN/AGREIGoldman Sachs Future Real Estate and Infrastructure Equity ETFN/AN/AN/AN/AN/AN/AN/AN/ASIMSSPDR S&P Kensho Intelligent Structures ETFN/AN/AN/AN/AN/AN/AN/AN/AXPNDFirst Trust Expanded Technology ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCANCTema Oncology ETFN/AN/A$40.2355.07% UpsideGREIGoldman Sachs Future Real Estate and Infrastructure Equity ETF0.00N/A$36.8615.62% UpsideSIMSSPDR S&P Kensho Intelligent Structures ETF0.00N/A$43.2631.38% UpsideXPNDFirst Trust Expanded Technology ETF0.00N/A$28.029.37% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCANCTema Oncology ETFN/AN/AN/AN/AN/AN/AGREIGoldman Sachs Future Real Estate and Infrastructure Equity ETFN/AN/AN/AN/AN/AN/ASIMSSPDR S&P Kensho Intelligent Structures ETFN/AN/AN/AN/AN/AN/AXPNDFirst Trust Expanded Technology ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCANCTema Oncology ETFN/AN/A26.86∞N/AN/AN/AN/AN/AGREIGoldman Sachs Future Real Estate and Infrastructure Equity ETFN/AN/A22.91∞N/AN/AN/AN/AN/ASIMSSPDR S&P Kensho Intelligent Structures ETFN/AN/A20.42∞N/AN/AN/AN/AN/AXPNDFirst Trust Expanded Technology ETFN/AN/A37.34∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCANCTema Oncology ETF$0.140.54%N/AN/AN/AGREIGoldman Sachs Future Real Estate and Infrastructure Equity ETF$0.601.88%N/AN/AN/ASIMSSPDR S&P Kensho Intelligent Structures ETF$0.491.49%N/AN/AN/AXPNDFirst Trust Expanded Technology ETF$0.050.20%N/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCANCTema Oncology ETFN/AGREIGoldman Sachs Future Real Estate and Infrastructure Equity ETFN/ASIMSSPDR S&P Kensho Intelligent Structures ETFN/AXPNDFirst Trust Expanded Technology ETFN/AInsider OwnershipCompanyInsider OwnershipCANCTema Oncology ETFN/AGREIGoldman Sachs Future Real Estate and Infrastructure Equity ETFN/ASIMSSPDR S&P Kensho Intelligent Structures ETFN/AXPNDFirst Trust Expanded Technology ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCANCTema Oncology ETFN/A680,000N/ANot OptionableGREIGoldman Sachs Future Real Estate and Infrastructure Equity ETFN/A600,000N/ANot OptionableSIMSSPDR S&P Kensho Intelligent Structures ETFN/A510,000N/ANot OptionableXPNDFirst Trust Expanded Technology ETFN/A700,002N/ANot OptionableGREI, SIMS, CANC, and XPND HeadlinesNo headlines for this company have been tracked by MarketBeat.comMedia Sentiment Over TimeCompany DescriptionsTema Oncology ETFNASDAQ:CANCThe Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.Goldman Sachs Future Real Estate and Infrastructure Equity ETFNYSEARCA:GREIThe Goldman Sachs Future Real Estate and Infrastructure Equity ETF (GREI) is an exchange-traded fund that mostly invests in real estate equity. The fund is an actively-managed portfolio that seeks long-term capital growth by investing in global real estate and infrastructure companies. GREI was launched on Nov 9, 2021 and is managed by Goldman Sachs.SPDR S&P Kensho Intelligent Structures ETFNYSEARCA:SIMSThe SPDR S&P Kensho Intelligent Structures ETF (SIMS) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks an index of US-listed companies that focuses on innovative infrastructure. SIMS was launched on Dec 26, 2017 and is managed by State Street.First Trust Expanded Technology ETFNYSEARCA:XPNDThe First Trust Expanded Technology ETF (XPND) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in US stocks whose businesses are derived from or dependent on technology. XPND was launched on Jun 14, 2021 and is managed by First Trust. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.